首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Anti-hypersensitivity effects of Shu-jing-huo-xue-tang, a Chinese herbal medicine, in CCI-neuropathic rats.
【24h】

Anti-hypersensitivity effects of Shu-jing-huo-xue-tang, a Chinese herbal medicine, in CCI-neuropathic rats.

机译:中药疏静活血汤对CCI神经病大鼠的抗超敏作用。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM OF THE STUDY: Shu-jing-huo-xue-tang (SJHXT) (Japanese name: Sokei-kakketu-to), a traditional Chinese herbal medicine composed of 17 crude drugs, has been prescribed over hundreds of years for treatment of chronic pain syndromes. We evaluated if oral SJHXT could suppress neuropathic pain behaviors in rats with chronic constriction injury (CCI) of the sciatic nerve. MATERIALS AND METHODS: (1) Rats received repeated oral SJHXT 0.5 or 1.0 g/kg once daily for 14 days starting 24 h after CCI surgery, while neuropathic manifestations were evaluated until day 20 post-CCI. (2) Other groups of rats received single oral SJHXT 1.0 g/kg on day 14 post-CCI. (3) Additional groups of rats received oral SJHXT 1.0 g/kg on day 14 post-CCI, concomitantly with intraperitoneal yohimbine 1 mg/kg or methysergide 5 mg/kg. Neuropathic manifestations, including mechanical allodynia and thermal hyperalgesia, were evaluated with paw withdrawal responses to increasing mechanical pressure and radiant heat, respectively. RESULTS: Mechanical allodynia and thermal hyperalgesia developed by day 14 post-CCI. Repeated oral SJHXT for 14 days produced anti-allodynic and anti-hyperalgesic effects that outlasted the period of drug administration. Single oral SJHXT on day 14 also produced significant anti-allodynic and anti-hyperalgesic effects, which were inhibited by yohimbine, an alpha-2 adrenoceptor antagonist, but not by methysergide, a serotonin receptor antagonist. CONCLUSIONS: Oral SJHXT produced anti-hypersensitivity effects by actions on alpha-2 adrenoreceptors in CCI-neuropathic rats, and chronic oral administration of SJHXT could produce the long-lasting anti-hypersensitivity effects.
机译:研究目的:数以百计的处方开出了由17种原料药组成的传统中草药Shu-jing-huo-xue-tang-sang(SJHXT)(日语名称:Sokei-kakketu-to)。疼痛综合症。我们评估了口服SJHXT是否能抑制坐骨神经慢性压迫性损伤(CCI)大鼠的神经性疼痛行为。材料与方法:(1)大鼠自CCI手术后24小时开始,每天重复口服SJHXT 0.5或1.0 g / kg,连续14天,每天一次,同时评估神经病变表现,直至CCI后第20天。 (2)其他组大鼠于CCI后第14天接受单次口服SJHXT 1.0 g / kg。 (3)另外几组大鼠在CCI后第14天接受口服SJHXT 1.0 g / kg,并伴有腹膜内育亨宾1 mg / kg或美塞麦肽5 mg / kg。分别通过对机械压力和辐射热增加的爪缩回反应评估了包括机械性异常性疼痛和热痛觉过敏在内的神经病变表现。结果:CCI后第14天出现机械性异常性疼痛和热痛觉过敏。重复口服SJHXT 14天可产生抗痛觉过敏和抗痛觉过敏作用,从而延长了药物治疗的时间。第14天单次口服SJHXT也产生了显着的抗痛觉过敏和抗痛觉过敏作用,但被约欣宾(α-2肾上腺素受体拮抗剂)抑制,但没有被5-羟色胺受体拮抗剂美塞麦肽(mythysergide)抑制。结论:口服SJHXT通过作用于CCI神经病大鼠的α-2肾上腺素受体而产生抗超敏作用,长期口服SJHXT可以产生持久的抗超敏作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号